v3.26.1
Condensed Statements of Changes in Shareholders' Equity (Deficit) (Unaudited) - USD ($)
Common Stock [Member]
Common Class A [Member]
Common Stock [Member]
Common Class B [Member]
Common Stock [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2025 $ 479 $ 24,521 $ (46,492) $ (21,492)
Balance, shares at Dec. 31, 2025 4,791,667 [1]      
Private placement, proceeds $ 31 3,149,969 3,150,000
Private placement, proceeds, shares 315,000      
Public rights, fair value 3,046,875 3,046,875
Offering costs allocated to public rights (42,923) (42,923)
Accretion for Class A ordinary shares subject to possible redemption (4,824,992) (4,824,992)
Net income 414,794 414,794
Balance at Mar. 31, 2026 $ 31 $ 479 1,353,450 368,302 1,722,262
Balance, shares at Mar. 31, 2026 315,000 4,791,667      
Balance at Dec. 31, 2025 $ 479 24,521 (46,492) (21,492)
Balance, shares at Dec. 31, 2025 4,791,667 [1]      
Net income         1,344,917
Balance at Jun. 30, 2026 $ 31 $ 417 265,111 1,298,425 1,563,984
Balance, shares at Jun. 30, 2026 315,000 4,171,667      
Balance at Mar. 31, 2026 $ 31 $ 479 1,353,450 368,302 1,722,262
Balance, shares at Mar. 31, 2026 315,000 4,791,667      
Accretion for Class A ordinary shares subject to possible redemption (1,088,401) (1,088,401)
Net income 930,123 930,123
Forfeiture of Class B ordinary shares $ (62) 62
Forfeiture of Class B ordinary shares, shares   (620,000)      
Balance at Jun. 30, 2026 $ 31 $ 417 $ 265,111 $ 1,298,425 $ 1,563,984
Balance, shares at Jun. 30, 2026 315,000 4,171,667      
[1] Includes 625,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5). Shares and associated accounts have been retroactively restated to reflect the surrender of 958,333 Class B ordinary shares for no consideration on February 23, 2026. On February 26, 2026, the underwriters partially exercised their over-allotment option and purchased an additional 15,000 units at the public offering price (see note 7). The underwriters did not exercise the remaining portion of the over-allotment option, and the option expired unexercised at the end of the 45-day period following the closing of the Initial Public Offering. As a result, 620,000 Class B ordinary shares were surrendered on April 11, 2026.